Roche Deutschland Holding GmbH
Germany
1 December 2019 - 30 November 2020
Principal institution: F. Hoffmann-La Roche AG
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Roche Deutschland Holding GmbH published between 1 December 2019 - 30 November 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
16 | 3.56 |
Outputs by subject (Share)
Subject | Count | Share | |
---|---|---|---|
Life Sciences | 12 | 1.81 | |
Chemistry | 4 | 1.75 | |
Physical Sciences | 1 | 0.19 |
Top articles by Altmetric score in current window
Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapy.
Proceedings of the National Academy of Sciences of the United States of America
2019-12-30
Insights into the mechanism of coreactant electrochemiluminescence facilitating enhanced bioanalytical performance
Nature Communications
2020-05-29
NK cell–derived GM-CSF potentiates inflammatory arthritis and is negatively regulated by CIS
Journal of Experimental Medicine
2020-05-04
Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy
Science Translational Medicine
2020-03-11

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.